A Canterbury woman dismissed postmenopausal bleeding as a menopause symptom—only to be diagnosed with womb cancer. Now cancer ...

The FDA has approved the BLA for Ospomyv™ and Xbryk™, biosimilars to Prolia (denosumab) and Xgeva (denosumab), respectively.

Leukocyte count is an independent predictor of future long COVID in postmenopausal women, according to study findings.

Intermittent fasting may benefit antioxidant and inflammatory markers in postmenopausal women with rheumatoid arthritis, according to a study published online Jan. 18 in Scientific Reports.

Please provide your email address to receive an email when new articles are posted on . Postmenopausal women with vulvovaginal atrophy treated with prasterone had lower UTI prevalence. Women who ...

Osteoporosis, often called a silent disease, weakens bones and increases the risk of fractures, making it a leading cause of ...

In a study of approximately 386,000 women published in JAMA Network Open, almost half of those who took antidepressants ...

OSPOMYV, referencing Prolia, has been approved for the treatment of postmenopausal women with osteoporosis at high risk for fracture, treatment to increase bone mass in men with osteoporosis at high ...

Intermittent fasting may benefit antioxidant and inflammatory markers in postmenopausal women with rheumatoid arthritis.

Osteoporosis, often called a silent disease, weakens bones and increases the risk of fractures, making it a leading cause of ...